A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Genetics Study finds potential therapeutic target for prostate cancers with PTEN mutation September 26, 2019 PTEN, a tumour suppressor gene mutated in approximately 20% of primary prostate cancers, and in…